Owners of CFMOTO Recreational Off-Highway Vehicles (ROVs) should stop driving them immediately and contact a CFMOTO dealer to schedule a free repair of a fuel line fitting, which can fail to securely lock into the fuel injector inlet and allow fuel to spill onto the hot engine parts and ignite, according to the Consumer Product Safety Commission (CPSC). About 500 ROVs are affected. CFMOTO is also contacting all registered owners and dealers directly about the issue.

ROV recall for web 375x210 CFMOTO recalls ROVs due to engine fire riskCFMOTO has received two reports of the fuel injector connection not fully secure and locked in place, causing a fuel leak. In one incident, the vehicle engine caught on fire. No injuries were reported.

This recall involves the 2020 ZFORCE 950 Sport ROV with a 963cc 4-cycle engine. Vehicle colors are red or gray with the CFMOTO logo in the center of the front grille. The model name is located on each side of the vehicle doors. The model year 2020 ROVs will have the L in the 10th position of the vehicle identification number (VIN). The VIN number is stamped on the right-side frame rail, behind the right rear tire.

The ROVs were sold from CFMOTO dealers nationwide from June 2020 to August 2020 for about $13,000. Consumers with questions can call CFMOTO at 888-823-6686, email info@cfmotousa.com or go online at www.cfmotousa.com and click on Customer Care, then Vehicle Safety for more information.

We're here to help!

We live by our creed of “helping those who need it most” and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked * may be required for submission.

Continuing the battle with Big Pharma

The entire Beasley Allen staff had our personal interest at heart. We were part of the family of a down to earth, trustworthy, understanding law firm. Thank you, Beasley Allen, for continuing the battle with Big Pharma.

—Richard